
Lexicon Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Lexicon Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lexicon Pharmaceuticals Inc
Access all reports
Lexicon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of diseases with significant unmet medical needs. The company leverages its expertise in gene science to discover and develop small-molecule drugs aimed at addressing serious conditions such as heart disease, diabetes, and cancer. Lexicon's drug development approach involves targeting specific molecular pathways to create novel therapies that can alter the course of these diseases and improve patient outcomes. The company is headquartered in The Woodlands, Texas, and its shares are listed on the NASDAQ.
Key slides for Lexicon Pharmaceuticals Inc


Corporate Presentation
Lexicon Pharmaceuticals Inc


Corporate Presentation
Lexicon Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LXRX
Country
🇺🇸 United States